Stock listing

Proqr Therapeutics N.v.

Selected listing: 0PQ · TRADEGATE · EUR · DE

Proqr Therapeutics N.v. (Tradegate:0PQ), Health Technology. Latest release Sep 23, 2026: ProQR Announces Appointment of Chris Hart as Chief Data and AI…

0PQ:TRADEGATEEURDEUpdated October 2, 2026

Ticker: Tradegate:0PQ
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Tradegate
Currency: EUR

Latest news from Proqr Therapeutics N.v.

ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor

September 23, 2026

ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026

September 9, 2026

ProQR to Participate in Upcoming Investor Conferences in September 2026

September 2, 2026

ProQR Announces Second Quarter 2026 Operating and Financial Results

August 13, 2026

ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement

June 25, 2026

All Proqr Therapeutics N.v. news →

Events

Replays

ProQR Therapeutics N.V. (PRQR) Q1 2024 Earnings Call
Thu, May 09, 2024 · 08:00 AM ET
Watch

Research Proqr Therapeutics N.v.

Proqr Therapeutics N.v. company profile

View the public company page for Proqr Therapeutics N.v. on 6ix.

Proqr Therapeutics N.v. news

Read company news and market updates connected to Proqr Therapeutics N.v..

Proqr Therapeutics N.v. investor events

Find investor webinars, events, and replay context for Proqr Therapeutics N.v..